Global Pulmonary Nodule Localization Needle Market
授權報價
| Single User | $3,950 USD |
| Multi User | $4,850 USD |
| Enterprise / Global Site Licence | $7,550 USD |
完整報告名稱與涵蓋範圍
Global Pulmonary Nodule Localization Needle Market Size By Type (Hook-Wire Needle, Four-Hook Needle), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs)) By Geographic Scope And Forecast
報告摘要
Global Pulmonary Nodule Localization Needle Market Analysis
According to Verified Market Research, the Global Pulmonary Nodule Localization Needle Market was valued at USD 68.85 Million in 2025 and is projected to reach USD 114.72 Million by 2033, growing at a CAGR of 6.63% from 2027 to 2033.
The global market for pulmonary nodule localization needles is being driven by the increased detection of tiny and early-stage lung nodules owing to the rising use of low-dose CT screening programs. The development in minimally invasive thoracic surgeries, particularly robotic and video-assisted procedures, has raised the need for precise preoperative localization methods. The increasing incidence of lung cancer, particularly in older populations, continues to sustain procedural volumes. Advances in image guidance and localization techniques are improving clinical outcomes and surgeon confidence. Growing healthcare infrastructure in emerging countries and a greater emphasis on lung-conserving surgical procedures are also contributing to sustained market expansion.
Global Pulmonary Nodule Localization Needle Market Definition
A pulmonary nodule localization needle is a specialized medical device that is typically used during minimally invasive thoracic operations to accurately pinpoint small or non-palpable lung nodules before they are surgically removed. It can be challenging to visually recognize or physically palpate these nodules during surgery, especially if they are small, deep-seated, or have a ground-glass look. These nodules are sometimes discovered by accident during low-dose CT screening or diagnostic imaging. As a result, localization needles are used to precisely direct surgeons to the target lesion, cutting down on operating time and boosting surgical confidence.
Shortly before surgery, the device is usually implanted percutaneously under imaging guidance, most frequently computed tomography. The needle uses an anchoring device, such as a hook-wire or multi-hook system, to secure the marker in place within the lung tissue once it has been placed next to or inside the pulmonary nodule. During video-assisted thoracoscopic surgery or robotic-assisted surgeries, the external part of the wire or marker serves as a tactile and visible reference to help surgeons pinpoint the precise site of the lesion. Localization needles limit the possibility of excessive tissue excision and conversion to open surgery by providing a clear spatial roadmap.
Lung-conserving surgical techniques are made possible in large part by pulmonary nodule localization needles. Surgeons can conduct limited resections, like wedge resections or segmentectomies, while maintaining healthy lung tissue by using accurate localization. Patients undergoing recurrent interventions or those with impaired pulmonary function should pay special attention to this. By guaranteeing that the appropriate lesion is removed and sent for pathological analysis, the use of localization devices also helps to improve diagnostic accuracy.
Pulmonary nodule localization needles have become an important part of thoracic surgical workflows as lung cancer screening programs spread throughout the world and the detection rate of early-stage pulmonary nodules rises. Their application contributes to the more general trend of minimally invasive, precision-guided procedures meant to enhance operating room efficiency, lower procedural risk, and improve patient outcomes.
Global Pulmonary Nodule Localization Needle Market Overview
The global pulmonary nodule localization needle market has expanded in step with broader changes in lung cancer detection and minimally invasive surgery. The need for accurate preoperative localization methods has increased as low-dose CT screening and incidental CT findings increase the number of tiny, non-palpable nodules found. Radiology and thoracic surgery teams are experiencing more consistent procedure throughput as a result of increased referral volumes for localization and biopsy operations brought about by advancements in imaging methods and the gradual inclusion of AI tools for nodule diagnosis.
Although alternative methods like microcoils, lipiodol marking, and dye or marker injections are gaining popularity where hook-wire limitations (such as dislodgement) are a concern, hook-wire and multi-hook anchoring systems are still commonly used in clinical settings because they provide simple, intraoperative guidance for video-assisted thoracoscopic surgery. Procurement decisions in higher-volume institutions are being influenced by comparative clinical studies that show some anchored or microcoil systems have better localization success and lower complication rates than traditional hook-wire procedures.
Commercial manufacturers that sell disposable localization kits and related devices, as well as major OEMs, constitute the market. While European and North American companies frequently compete on clinical evidence and distribution reach, East Asian vendors are well-represented in the product catalog and export flows. Easy deployment under CT guidance, patient comfort, and compliance with quick turnover operating room operations are becoming more and more important factors in product differentiation.
Future growth will be primarily driven by scaling screening programs, moving some procedures to outpatient settings, and gradually shifting clinician preferences toward technologies that reduce OR waits and complication rates. Regulatory channels, hospital funding for preoperative localization, and continuing data comparing localization modalities will determine which technologies earn larger market shares over the next five years. Vendors who can demonstrate a clear therapeutic advantage and streamline logistics for interdisciplinary teams stand to gain the most from rising treatment volumes.
Global Pulmonary Nodule Localization Needle Market: Segmentation Analysis
The Global Pulmonary Nodule Localization Needle Market is segmented based on Type, End-User, and Region.
Global Pulmonary Nodule Localization Needle Market, By Type
Hook-Wire Needle
Four-Hook Needle
Hook-wire needles account for the largest share of the global market for pulmonary nodule localization needles within the type segmentation. They are the preferred option in many hospitals and diagnostic facilities owing to their extensive availability, long history of clinical use, and ease of deployment under CT guidance. Hook-wire systems are well-known to surgeons and interventional radiologists, which reduces training needs and promotes consistent procedure results. Furthermore, hook-wire needles are typically less expensive than multi-hook versions, which makes them appealing in healthcare environments where costs are important. The established base and regular use of hook-wire needles maintain their dominant market position even in the face of the introduction of four-hook versions.
Global Pulmonary Nodule Localization Needle Market, By End-User
Hospitals
Specialty Clinics
Ambulatory Surgical Centers (ASCs)
Others
Hospitals are the largest market for pulmonary nodule localization needles across the end-user segmentation. Due to the requirement for advanced imaging facilities, interdisciplinary thoracic surgery teams, and quick access to operating rooms, the majority of localization procedures are carried out in hospital settings. Additionally, hospitals deal with a greater number of complicated and cancer-related situations, where accurate localization is essential to the success of surgery. The number of procedures is also influenced by the existence of well-established lung cancer screening programs in large hospital networks. Because of this, hospitals continue to be the world's largest consumers and buyers of pulmonary nodule localization needles.
Global Pulmonary Nodule Localization Needle Market, By Region
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
For pulmonary nodule localization needles, the Asia Pacific is the world's largest regional market. Due to factors including population size, smoking frequency in several countries, and increased availability of diagnostic imaging, the region has a very high number of lung cancer cases. Preoperative localization devices are in high demand owing to the increasing rise of CT-based screening and minimally invasive thoracic procedures, particularly in China, Japan, and South Korea. Furthermore, increased product availability and reasonable prices because of the robust presence of regional manufacturers have encouraged broader usage in both public and private hospitals.
Global Pulmonary Nodule Localization Needle Market Competitive Landscape
The “Global Pulmonary Nodule Localization Needle Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Curaway, SOMATEX, Zoray Precision, Haolang Medical, Jiangsu Guanchuang Medical Technology Co. Ltd., Ningbo Senscure Biotechnology Co. Ltd., Cryofocus Medtech (Shanghai) Co. Ltd., and Others. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
目錄 Table of Contents
1 INTRODUCTION
1.1 MARKET DEFINITION
1.2 MARKET SEGMENTATION
1.3 RESEARCH TIMELINES
1.4 ASSUMPTIONS
1.5 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 DATA MINING
2.2 SECONDARY RESEARCH
2.3 PRIMARY RESEARCH
2.4 SUBJECT MATTER EXPERT ADVICE
2.5 QUALITY CHECK
2.6 FINAL REVIEW
2.7 DATA TRIANGULATION
2.8 BOTTOM-UP APPROACH
2.9 TOP-DOWN APPROACH
2.10 RESEARCH FLOW
2.11 DATA SOURCES
3 EXECUTIVE SUMMARY
3.1 GLOBAL PULMONARY NODULE LOCALIZATION NEEDLE MARKET OVERVIEW
3.2 GLOBAL PULMONARY NODULE LOCALIZATION NEEDLE MARKET ESTIMATES AND FORECAST (USD MILLION)
3.3 GLOBAL PULMONARY NODULE LOCALIZATION NEEDLE MARKET ECOLOGY MAPPING
3.4 COMPETITIVE ANALYSIS: FUNNEL DIAGAM
3.5 GLOBAL PULMONARY NODULE LOCALIZATION NEEDLE MARKET ABSOLUTE MARKET OPPORTUNITY
3.6 GLOBAL PULMONARY NODULE LOCALIZATION NEEDLE MARKET ATTRACTIVENESS ANALYSIS, BY REGION
3.7 GLOBAL PULMONARY NODULE LOCALIZATION NEEDLE MARKETATTRACTIVENESS ANALYSIS, BY TYPE
3.8 GLOBAL PULMONARY NODULE LOCALIZATION NEEDLE MARKET ATTRACTIVENESS ANALYSIS, BY END USER
3.9 GLOBAL PULMONARY NODULE LOCALIZATION NEEDLE MARKET GEOGRAPHICAL ANALYSIS (CAGR %)
3.10 GLOBAL PULMONARY NODULE LOCALIZATION NEEDLE MARKET, BY TYPE(USD MILLION)
3.11 GLOBAL PULMONARY NODULE LOCALIZATION NEEDLE MARKET, BY END USER (USD MILLION)
3.12 GLOBAL PULMONARY NODULE LOCALIZATION NEEDLE MARKET, BY GEOGRAPHY (USD MILLION)
3.13 FUTURE MARKET OPPORTUNITIES
4 MARKET OUTLOOK
4.1 GLOBAL PULMONARY NODULE LOCALIZATION NEEDLE MARKETEVOLUTION
4.2 GLOBAL PULMONARY NODULE LOCALIZATION NEEDLE MARKET OUTLOOK
4.3 MARKET DRIVERS
4.4 MARKET RESTRAINTS
4.5 MARKET TRENDS
4.6 MARKET OPPORTUNITY
4.7 PORTER’S FIVE FORCES ANALYSIS
4.7.1 THREAT OF NEW ENTRANTS
4.7.2 BARGAINING POWER OF SUPPLIERS
4.7.3 BARGAINING POWER OF BUYERS
4.7.4 THREAT OF SUBSTITUTE TYPES
4.7.5 COMPETITIVE RIVALRY OF EX9ISTING COMPETITORS
4.8 VALUE CHAIN ANALYSIS
4.9 PRICING ANALYSIS
4.10 MACROECONOMIC ANALYSIS
5 MARKET, BY TYPE
5.1 OVERVIEW
5.2 GLOBAL PULMONARY NODULE LOCALIZATION NEEDLE MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY TYPE
5.3 HOOK-WIRE NEEDLE
5.4 FOUR-HOOK NEEDLE
6 MARKET, BY END USER
6.1 OVERVIEW
6.2 GLOBAL PULMONARY NODULE LOCALIZATION NEEDLE MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY END USER
6.3 HOSPITALS
6.4 SPECIALTY CLINICS
6.5 AMBULATORY SURGICAL CENTERS (ASCS)
7 MARKET, BY GEOGRAPHY
7.1 OVERVIEW
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 CANADA
7.2.3 MEXICO
7.3 EUROPE
7.3.1 GERMANY
7.3.2 U.K.
7.3.3 FRANCE
7.3.4 ITALY
7.3.5 SPAIN
7.3.6 REST OF EUROPE
7.4 ASIA PACIFIC
7.4.1 CHINA
7.4.2 JAPAN
7.4.3 INDIA
7.4.4 REST OF ASIA PACIFIC
7.5 LATIN AMERICA
7.5.1 BRAZIL
7.5.2 ARGENTINA
7.5.3 REST OF LATIN AMERICA
7.6 MIDDLE EAST AND AFRICA
7.6.1 UAE
7.6.2 SAUDI ARABIA
7.6.3 SOUTH AFRICA
7.6.4 REST OF MIDDLE EAST AND AFRICA
8 COMPETITIVE LANDSCAPE
8.1 OVERVIEW
8.2 KEY DEVELOPMENT STRATEGIES
8.3 COMPANY REGIONAL FOOTPRINT
8.4 ACE MATRIX
8.4.1 ACTIVE
8.4.2 CUTTING EDGE
8.4.3 EMERGING
8.4.4 INNOVATORS
9 COMPANY PROFILES
9.1 OVERVIEW
9.2 CURAWAY
9.3 SOMATEX
9.4 ZORAY PRECISION
9.5 HAOLANG MEDICAL
9.6 NGSU GUANCHUANG MEDICAL TECHNOLOGY CO. LTD
9.7 NINGBO SENSCURE BIOTECHNOLOGY CO. LTD
9.8 CRYOFOCUS MEDTECH (SHANGHAI) CO. LTD
同分類最新報告(醫療器材)
常見問題
這份報告可以先索取樣本嗎?
可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算?
報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付?如何付款?
一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。
量子訊息有限公司為 Verified Market Research 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們